camptothecin has been researched along with cbp-93872 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, Y; Harada, N; Makishima, F; Nakanishi, K; Nakanishi, M; Sakumoto, H; Tsuchiya, M; Watanabe, Y; Yoshimura, Y | 1 |
1 other study(ies) available for camptothecin and cbp-93872
Article | Year |
---|---|
Identification of a checkpoint modulator with synthetic lethality to p53 mutants.
Topics: Aniline Compounds; Antineoplastic Agents; Camptothecin; CDC2 Protein Kinase; Cell Proliferation; Checkpoint Kinase 1; Cyclin B; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; G1 Phase; G2 Phase; High-Throughput Screening Assays; HT29 Cells; Humans; Mutation; Phosphorylation; Propanolamines; Protein Kinases; Reproducibility of Results; Tumor Suppressor Protein p53 | 2011 |